Cite
MLA Citation
R. Lombardi et al.. “Fibroscan liver stiffness (LMS) and controlled attenuation parameter (CAP) in the evaluation of cardiovascular risk assessment in patients with NAFLD.” Digestive and liver disease, vol. 50, no. 1, n.d., pp. 37–. http://access.bl.uk/ark:/81055/vdc_100057143396.0x00000f